Home NDC 51407-132-01 DISOPYRAMIDE PHOSPHATE
Product NDC 51407-132
Requested package NDC 51407-132-01
11-digit product format 514070132
Labeler code 51407
Product ID 51407-132_7b2218ae-a394-22d0-e053-2a91aa0a769d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DISOPYRAMIDE PHOSPHATE
Dosage form CAPSULE
Route ORAL
Labeler Golden State Medical Supply Inc.
Application ANDA070173
Marketing category ANDA
Marketing start 1985-05-31
Marketing end 0000-00-00
Substance DISOPYRAMIDE PHOSPHATE
Active strength 150 mg/1
Pharmacologic classes Antiarrhythmic [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A070173-001 DISOPYRAMIDE PHOSPHATE DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 A070173-002 DISOPYRAMIDE PHOSPHATE DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL AB 1985-05-31 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL AB 1985-05-31 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL 1985-05-31 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL 1985-05-31 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A070173-001 DISOPYRAMIDE PHOSPHATE EQ 100MG BASE CAPSULE / ORAL 1985-05-31 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A070173-002 DISOPYRAMIDE PHOSPHATE EQ 150MG BASE CAPSULE / ORAL 1985-05-31 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 76 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 51407-132-01 51407013201 100 CAPSULE in 1 BOTTLE (51407-132-01) 100 capsule 2018-07-02 0000-00-00 No No Current